Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
NVCR NovoCure Limited daily Stock Chart
NVCR [NASD]
NovoCure Limited
Healthcare | Medical Appliances & Equipment | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.59 Insider Own2.10% Shs Outstand99.21M Perf Week-1.06%
Market Cap5.46B Forward P/E103.92 EPS next Y0.53 Insider Trans-51.20% Shs Float77.88M Perf Month11.81%
Income-55.00M PEG- EPS next Q-0.07 Inst Own74.60% Short Float4.71% Perf Quarter7.01%
Sales269.30M P/S20.29 EPS this Y36.50% Inst Trans12.30% Short Ratio7.60 Perf Half Y52.41%
Book/sh1.33 P/B41.41 EPS next Y365.00% ROA-16.50% Target Price54.40 Perf Year72.39%
Cash/sh2.59 P/C21.30 EPS next 5Y- ROE-47.20% 52W Range26.02 - 57.82 Perf YTD64.52%
Dividend- P/FCF719.01 EPS past 5Y5.90% ROI-19.60% 52W High-4.74% Beta2.37
Dividend %- Quick Ratio4.40 Sales past 5Y88.70% Gross Margin69.70% 52W Low111.68% ATR2.00
Employees598 Current Ratio4.70 Sales Q/Q40.70% Oper. Margin-10.10% RSI (14)59.56 Volatility4.05% 3.46%
OptionableYes Debt/Eq1.18 EPS Q/Q44.40% Profit Margin-20.40% Rel Volume0.77 Prev Close57.06
ShortableYes LT Debt/Eq1.18 EarningsMay 02 BMO Payout- Avg Volume483.22K Price55.08
Recom2.20 SMA203.80% SMA5012.62% SMA20023.68% Volume370,941 Change-3.47%
Mar-20-19Initiated SunTrust Hold
Nov-02-18Downgrade Wells Fargo Outperform → Market Perform
Jul-16-18Initiated Evercore ISI Outperform $46
Apr-18-18Reiterated Mizuho Buy $28 → $32
Feb-23-18Reiterated Mizuho Buy $25 → $28
May-24-17Upgrade Wells Fargo Market Perform → Outperform
Jul-29-16Reiterated Wedbush Outperform $30 → $20
Jan-19-16Initiated Barclays Underweight $16
Dec-02-15Initiated Deutsche Bank Hold $28
Oct-27-15Initiated Wedbush Outperform
Oct-27-15Initiated JP Morgan Overweight
Oct-27-15Initiated JMP Securities Mkt Outperform $43
Jun-14-19 09:08AM  Hedge Funds Have Never Been This Bullish On NovoCure Limited (NVCR) Insider Monkey
Jun-12-19 04:39PM  Why NovoCure's Regulatory News Is a Huge Win for Investors Motley Fool
03:13PM  Is NovoCure Limited's (NASDAQ:NVCR) CEO Overpaid Relative To Its Peers? Simply Wall St.
Jun-07-19 08:34AM  You Need This IPO On Your Radar Motley Fool
Jun-06-19 07:50AM  Why NovoCure Stock Jumped 20.5% in May Motley Fool
Jun-03-19 07:45AM  3 Fast-Growing Healthcare Stocks to Buy If the Market Crashes Motley Fool
May-24-19 07:44AM  The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice Benzinga +7.30%
07:30AM  Novocure to Participate in the Jefferies 2019 Global Healthcare Conference Business Wire
May-23-19 04:05PM  FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma Business Wire
May-13-19 03:00AM  Insulet and Novocure Are Going Gangbusters Motley Fool
May-10-19 06:30AM  Medicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed Glioblastoma Business Wire
May-08-19 04:10PM  Edited Transcript of NVCR earnings conference call or presentation 2-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-07-19 10:38AM  5 Key Takeaways From NovoCure's Big First-Quarter Motley Fool
May-03-19 12:48AM  NovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript Motley Fool +9.62%
May-02-19 12:02PM  NovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript Motley Fool
08:16AM  The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data Benzinga
07:30AM  NovoCure (NVCR) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:18AM  NovoCure: 1Q Earnings Snapshot Associated Press
06:00AM  Novocure Reports First Quarter 2019 Financial Results and Provides Company Update Business Wire
Apr-30-19 02:20PM  The NovoCure (NASDAQ:NVCR) Share Price Is Up 275% And Shareholders Are Boasting About It Simply Wall St.
07:30AM  Novocure Announces the International Journal of Radiation Oncology, Biology, Physics Publishes Data Demonstrating Higher Doses of Tumor Treating Fields Improved Survival of Newly Diagnosed Glioblastoma Patients Business Wire
07:01AM  Jim Cramer Weighs In On Canopy Growth, Levi, Twilio And More Benzinga
Apr-26-19 10:17AM  Did Hedge Funds Drop The Ball On NovoCure Limited (NVCR) ? Insider Monkey
Apr-25-19 10:33AM  NovoCure (NVCR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-15-19 07:30AM  Novocure Publishes 2018 Annual Report Featuring Companys Vision, Mission and Values Business Wire
Apr-10-19 02:10PM  What You Should Know About NovoCure Limited's (NASDAQ:NVCR) Financial Strength Simply Wall St.
Apr-06-19 03:45PM  Why Novocure Stock Fell More Than 10% in March Motley Fool
Apr-03-19 07:30AM  Inaugural AACR-Novocure Tumor Treating Fields Research Grant Recipients Announced at AACR Annual Meeting 2019 Business Wire
Apr-02-19 07:30AM  Novocure to Report First Quarter 2019 Financial Results Business Wire
Mar-29-19 07:50AM  Investor Expectations to Drive Momentum within Apple Hospitality REIT, Superior Energy Services, US Foods Holding, NovoCure, FTS International, and Envestnet Discovering Underlying Factors of Influence GlobeNewswire
Mar-22-19 07:30AM  Novocure Initiates Phase 3 Pivotal Trial in Recurrent Ovarian Cancer Business Wire -5.92%
Mar-21-19 07:30AM  Novocure Announces 48 Presentations and a Symposium Session on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2019 Business Wire
06:52AM  Novocure Chief Science Officer Eilon Kirson to retire after 7 years in the role MarketWatch
06:30AM  Novocures Chief Science Officer Retires after 17 Years of Service Business Wire
Mar-18-19 07:30AM  Novocure to Participate in Oppenheimers 29th Annual Healthcare Conference Business Wire
Mar-12-19 09:37AM  Does NovoCure Limiteds (NASDAQ:NVCR) Past Performance Indicate A Weaker Future? Simply Wall St.
Mar-08-19 08:45AM  Options Traders Expect Huge Moves in NovoCure (NVCR) Stock Zacks
Mar-04-19 11:58PM  Edited Transcript of NVCR earnings conference call or presentation 28-Feb-19 1:00pm GMT Thomson Reuters StreetEvents -5.83%
06:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $5.6 million of Shares GuruFocus.com
Feb-28-19 03:21PM  NovoCure (NVCR) Q4 2018 Earnings Conference Call Transcript Motley Fool
06:00AM  Novocure Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update Business Wire
Feb-21-19 11:49AM  3 Medical Device Companies for Your Watchlist Motley Fool
Jan-23-19 11:38AM  How Many Insiders Sold NovoCure Limited (NASDAQ:NVCR) Shares? Simply Wall St.
Jan-18-19 06:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $9 million of Shares GuruFocus.com
Jan-16-19 06:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $8.7 million of Shares GuruFocus.com
Jan-11-19 12:24PM  Tamarack Capital Managements Return, AUM, and Holdings Insider Monkey
Jan-07-19 04:05PM  Novocure Announces Fourth Quarter and Full Year 2018 Operating Statistics, Preliminary Net Revenues and Provides Company Update Business Wire
Dec-27-18 09:23AM  Stocks down in December for pharma firms in the Triangle American City Business Journals
Dec-24-18 09:44AM  Is NovoCure a Buy? Motley Fool
Dec-21-18 07:30AM  Novocure to Participate in the 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-17-18 02:20PM  What Kind Of Shareholder Owns Most NovoCure Limited (NASDAQ:NVCR) Stock? Simply Wall St.
07:30AM  Novocure and the AACR Announce Four Inaugural Research Grants to Promote and Support Innovative Research on Tumor Treating Fields Business Wire
Dec-16-18 09:10AM  Is NovoCure Limited (NVCR) A Good Stock To Buy? Insider Monkey
Dec-12-18 11:49AM  3 Top Medical Device Stocks to Buy Now Motley Fool
Dec-07-18 07:55AM  Recent Analysis Shows Moody's, Hershey, NovoCure, Mohawk Industries, La-Z-Boy, and Lockheed Martin Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Dec-06-18 07:30AM  Sub-Group Analysis of Novocures EF-14 Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Published in Journal of Neuro-Oncology Demonstrating More Time on Optune® Predicted Increased Survival Business Wire
Nov-14-18 07:30AM  Zai Lab and Novocure Awarded Deal of the Year GlobeNewswire
07:30AM  Novocure and Zai Lab Awarded Deal of the Year at 5th Annual BioCentury China Healthcare Summit in Shanghai, China Business Wire
Nov-13-18 08:01PM  3 Top Healthcare Stocks to Buy in November Motley Fool
08:24AM  Novocure Announces More than 70 Presentations on Tumor Treating Fields at 23rd Annual Meeting of the Society for Neuro-Oncology Business Wire
Nov-07-18 04:00PM  Novocure and Zai Lab to Host Investor Event Business Wire +8.33%
12:25PM  NovoCure Limited (NASDAQ:NVCR): Is Breakeven Near? Simply Wall St.
11:22AM  Here's Why NovoCure Fell 36.8% in October Motley Fool
Oct-30-18 02:04PM  Edited Transcript of NVCR earnings conference call or presentation 25-Oct-18 12:00pm GMT Thomson Reuters StreetEvents
07:30AM  New Research Coverage Highlights HomeStreet, Cousins Properties, Carbo Ceramics, Cowen Group, CTS, and NovoCure Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Oct-25-18 03:11PM  Here's Why Novocure Is Tumbling Today Motley Fool -18.98%
09:05AM  NovoCure (NVCR) Reports Q3 Loss, Misses Revenue Estimates Zacks
06:00AM  Novocure Reports Third Quarter 2018 Financial Results and Provides Company Update Business Wire
Oct-24-18 04:00PM  Novocure Founder Professor Yoram Palti and Director Louis J. Lavigne, Jr. Retire from Board of Directors Business Wire
Oct-23-18 05:57PM  Higher Delivered Dose of Tumor Treating Fields to Tumor Bed Associated with Improved Overall Survival in Newly Diagnosed Glioblastoma Business Wire
Oct-22-18 07:30AM  Pancreatology Publishes Results of the PANOVA Phase 2 Pilot Trial in Advanced Pancreatic Cancer Suggesting Improved Survival of Patients Treated with Tumor Treating Fields Business Wire
Oct-18-18 10:33AM  NovoCure (NVCR) Q3 Earnings Preview: What to Look Out For Zacks
07:30AM  Novocure Announces that the Medicare DME MACs Have Accepted the Local Coverage Determination Reconsideration Request for Optune® Business Wire
Oct-11-18 08:03AM  Why Novocure Stock Jumped 16.3% in September Motley Fool
Oct-04-18 09:08AM  Novocure Announces 55 Presentations at European Association of Neuro-Oncology Meeting 2018 Business Wire
Oct-02-18 11:51AM  3 Medical Devices Stocks to Buy InvestorPlace
Oct-01-18 08:36AM  Novocure to Report Third Quarter 2018 Financial Results Business Wire
Sep-25-18 07:30AM  Data from STELLAR Registration Trial of Tumor Treating Fields in Mesothelioma to be Presented at the IASLC 19th World Conference on Lung Cancer Business Wire
Sep-14-18 03:04PM  What Investors Should Know About NovoCure Limiteds (NASDAQ:NVCR) Financial Strength Simply Wall St.
Sep-13-18 10:57AM  5 Medical Device Stocks With Impressive Staying Power InvestorPlace
Sep-12-18 07:30AM  Novocure and Zai Lab Announce Strategic Collaboration with a License Agreement for Tumor Treating Fields in Greater China Business Wire
Sep-10-18 10:31AM  Why Novocure Gained 33% in August Motley Fool
Sep-06-18 11:24AM  Stocks - Cloudera, Verint Systems, Novocure Soar in Pre-market; Lands' End Tumbles Investing.com +5.34%
08:00AM  Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and NovoCure ACCESSWIRE
Sep-05-18 05:00PM  Tumor Treating Fields Plus Standard of Care Chemotherapy Significantly Extends Median Overall Survival by 6.1 Months in STELLAR Phase 2 Registration Trial in Mesothelioma Compared to Historical Control Business Wire
Aug-31-18 04:38PM  This brain cancer drug stock has been on a tear Yahoo Finance
Aug-26-18 07:15PM  3 Small-Cap Healthcare Stocks for Your Watch List Motley Fool
Aug-24-18 08:00AM  Today's Research Reports on Trending Tickers: Exact Sciences and NovoCure ACCESSWIRE
Aug-23-18 07:55AM  Research Report Identifies Genesis Healthcare, Maiden, Ichor, Armstrong World Industries, Rexnord, and NovoCure with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-17-18 07:30AM  This $7 Biotech Stock Could Be Worth $20 or More After Recent Developments ACCESSWIRE
Aug-15-18 08:38AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:30AM  Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer Business Wire
Aug-06-18 12:18PM  Forget Bitcoin: You're Better Off Buying These 3 Stocks Motley Fool
Aug-03-18 07:30AM  Novocure to Present at Two Upcoming Investor Conferences Business Wire
Aug-02-18 07:30AM  Novocure Announces Addition to Its Board of Directors Business Wire
Jul-31-18 07:30AM  Gynecologic Oncology Publishes Results of the INNOVATE Phase 2 Pilot Study Demonstrating Combination of Tumor Treating Fields with Paclitaxel May Improve Survival of Patients with Recurrent Ovarian Cancer Business Wire
Jul-26-18 07:19PM  Edited Transcript of NVCR earnings conference call or presentation 26-Jul-18 12:00pm GMT Thomson Reuters StreetEvents
06:00AM  Novocure Reports Second Quarter 2018 Financial Results and Provides Company Update Business Wire
Jul-19-18 07:30AM  Novocure Announces 13 Presentations at American Society for Radiation Oncology 2018 Annual Meeting Business Wire
Jul-17-18 08:54AM  NovoCure (NVCR) Catches Eye: Stock Jumps 7.4% Zacks
Markets a wearable electric field device for treating glioblastoma brain cancer.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Danziger AsafChief Executive OfficerJun 12Option Exercise14.3730,436437,365288,747Jun 13 04:16 PM
Danziger AsafChief Executive OfficerJun 12Sale55.3930,4361,685,965258,311Jun 13 04:16 PM
Danziger AsafChief Executive OfficerJun 11Option Exercise14.3716,835241,919275,146Jun 13 04:16 PM
Danziger AsafChief Executive OfficerJun 11Sale54.7516,835921,651258,311Jun 13 04:16 PM
LEUNG GABRIELDirectorJun 10Option Exercise3.445,00017,20074,504Jun 12 04:12 PM
LEUNG GABRIELDirectorJun 10Sale55.055,000275,26669,504Jun 12 04:12 PM
Shah PriteshChief Commercial OfficerJun 10Sale55.051,13062,21276,212Jun 12 04:13 PM
Ambrogi Michael J.Chief Operating OfficerJun 06Option Exercise7.155,99942,893191,673Jun 10 04:13 PM
Ambrogi Michael J.Chief Operating OfficerJun 06Sale54.795,999328,661185,674Jun 10 04:13 PM
Ambrogi Michael J.Chief Operating OfficerJun 05Option Exercise7.1517,500125,125203,174Jun 06 04:10 PM
Ambrogi Michael J.Chief Operating OfficerJun 05Sale54.1417,500947,485185,674Jun 06 04:10 PM
Ambrogi Michael J.Chief Operating OfficerJun 04Option Exercise7.1517,500125,125203,174Jun 05 04:33 PM
Ambrogi Michael J.Chief Operating OfficerJun 04Sale53.1217,500929,613185,674Jun 05 04:33 PM
Ambrogi Michael J.Chief Operating OfficerJun 03Option Exercise7.1517,500125,125203,174Jun 05 04:33 PM
Ambrogi Michael J.Chief Operating OfficerJun 03Sale52.1217,500912,128185,674Jun 05 04:33 PM
DOYLE WILLIAM FExecutive ChairmanMay 30Sale53.0748,1002,552,523846,463Jun 03 04:08 PM
PHILLIPS CHARLES G IIIDirectorMay 29Option Exercise9.1695,100871,16559,504May 31 04:11 PM
DOYLE WILLIAM FExecutive ChairmanMay 29Sale53.101,900100,881894,563May 31 04:12 PM
PHILLIPS CHARLES G IIIDirectorMay 29Sale52.1795,1004,961,1989,504May 31 04:11 PM
Burkoth William T.DirectorMay 21Option Exercise48.876,145300,3066,145May 22 04:27 PM
LEUNG GABRIELDirectorMay 21Option Exercise48.876,145300,30666,145May 22 04:26 PM
VERNON W ANTHONYDirectorMay 21Option Exercise48.876,145300,306255,230May 22 04:25 PM
PHILLIPS CHARLES G IIIDirectorMay 21Option Exercise48.876,145300,3066,145May 22 04:24 PM
Madden Martin J.DirectorMay 21Option Exercise48.878,906435,2368,906May 22 04:21 PM
LEUNG GABRIELDirectorMay 10Option Exercise3.445,00017,20065,000May 14 04:08 PM
LEUNG GABRIELDirectorMay 10Sale49.795,000248,95060,000May 14 04:08 PM
DOYLE WILLIAM FExecutive ChairmanMay 09Sale47.3731,4601,490,386896,463May 10 04:13 PM
DOYLE WILLIAM FExecutive ChairmanMay 08Option Exercise47.6258,7682,798,532927,923May 09 04:20 PM
DOYLE WILLIAM FExecutive ChairmanMay 08Sale47.5232,2181,531,032869,155May 09 04:20 PM
DOYLE WILLIAM FExecutive ChairmanMay 07Option Exercise48.9258,7682,874,931901,373May 09 04:20 PM
DOYLE WILLIAM FExecutive ChairmanMay 07Sale47.6732,0981,530,112842,605May 09 04:20 PM
DOYLE WILLIAM FExecutive ChairmanMay 06Option Exercise48.8958,7682,873,168874,703May 07 04:28 PM
DOYLE WILLIAM FExecutive ChairmanMay 06Sale48.0729,0381,395,915815,935May 07 04:28 PM
DOYLE WILLIAM FExecutive ChairmanMay 03Option Exercise44.6058,7682,621,053844,973May 06 05:48 PM
DOYLE WILLIAM FExecutive ChairmanMay 03Sale45.2129,9661,354,643786,205May 06 05:48 PM
DOYLE WILLIAM FExecutive ChairmanMay 02Option Exercise43.2858,7682,543,479816,171May 06 05:48 PM
Shah PriteshChief Commercial OfficerMay 02Sale43.801,20452,72977,342May 03 04:15 PM
Shah PriteshChief Commercial OfficerMay 01Option Exercise44.072,334102,85978,546May 03 04:15 PM
LEUNG GABRIELDirectorApr 10Option Exercise3.445,00017,20065,000Apr 12 04:05 PM
LEUNG GABRIELDirectorApr 10Sale45.955,000229,75060,000Apr 12 04:05 PM
Ambrogi Michael J.Chief Operating OfficerApr 02Option Exercise14.3715,516222,965201,190Apr 03 04:25 PM
Ambrogi Michael J.Chief Operating OfficerApr 02Sale47.2415,516733,039185,674Apr 03 04:25 PM
Ambrogi Michael J.Chief Operating OfficerApr 01Option Exercise13.3134,375457,594207,549Apr 03 04:25 PM
Ambrogi Michael J.Chief Operating OfficerApr 01Sale47.3934,3751,629,014185,674Apr 03 04:25 PM
Shah PriteshChief Commercial OfficerMar 28Option Exercise6.8032,521221,29176,212Apr 01 04:15 PM
LEUNG GABRIELDirectorMar 11Option Exercise3.445,00017,20065,000Mar 12 04:56 PM
LEUNG GABRIELDirectorMar 11Sale48.315,000241,55060,000Mar 12 04:56 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerMar 05Option Exercise3.4431,234107,44597,498Mar 06 04:18 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerMar 05Sale53.4031,2341,668,02166,264Mar 06 04:18 PM
Danziger AsafChief Executive OfficerMar 04Option Exercise14.3716,268233,771250,025Mar 06 04:17 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerMar 04Option Exercise3.4458,766202,155106,264Mar 06 04:18 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerMar 04Sale54.2258,7663,186,29166,264Mar 06 04:18 PM
Danziger AsafChief Executive OfficerMar 04Sale55.8916,268909,286233,757Mar 06 04:17 PM
Shah PriteshChief Commercial OfficerMar 01Option Exercise13.7740,586558,81042,136Mar 04 04:13 PM
Danziger AsafChief Executive OfficerMar 01Option Exercise14.37100,0001,437,000333,757Mar 04 04:15 PM
LEUNG GABRIELDirectorMar 01Option Exercise3.4425,00086,00085,000Mar 04 04:14 PM
Shah PriteshChief Commercial OfficerMar 01Sale55.6340,5862,257,69725,239Mar 04 04:13 PM
Danziger AsafChief Executive OfficerMar 01Sale55.57100,0005,556,582233,757Mar 04 04:15 PM
LEUNG GABRIELDirectorMar 01Sale55.0125,0001,375,27560,000Mar 04 04:14 PM
Danziger AsafChief Executive OfficerFeb 28Option Exercise14.3790312,976234,660Mar 01 04:31 PM
Longsworth Todd ChristopherGeneral CounselFeb 28Sale53.682,368127,11436,835Mar 01 04:30 PM
Danziger AsafChief Executive OfficerFeb 28Sale54.4090349,119233,757Mar 01 04:31 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerFeb 28Sale53.683,288176,50066,264Mar 01 04:36 PM
DOYLE WILLIAM FExecutive ChairmanFeb 28Sale53.683,097166,247918,306Mar 01 04:52 PM
Shah PriteshChief Commercial OfficerFeb 28Sale53.681,55883,63325,239Mar 01 04:32 PM
Ambrogi Michael J.Chief Operating OfficerFeb 28Sale53.682,397128,671169,305Mar 01 04:35 PM
Ambrogi Michael J.Chief Operating OfficerFeb 27Option Exercise52.906,174326,605171,702Mar 01 04:35 PM
Kirson Eilon D.Chief Science OfficerFeb 27Option Exercise52.906,945367,391152,408Mar 01 04:34 PM
Danziger AsafChief Executive OfficerFeb 27Option Exercise52.909,260489,854233,757Mar 01 04:31 PM
Shah PriteshChief Commercial OfficerFeb 27Option Exercise52.903,087163,30226,797Mar 01 04:32 PM
DOYLE WILLIAM FExecutive ChairmanFeb 27Option Exercise52.909,260489,854921,403Mar 01 04:52 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerFeb 27Option Exercise52.907,717408,22969,552Mar 01 04:36 PM
Longsworth Todd ChristopherGeneral CounselFeb 27Option Exercise52.905,556293,91239,203Mar 01 04:30 PM
Longsworth Todd ChristopherGeneral CounselFeb 25Sale53.639,325500,08133,647Feb 26 05:54 PM
Shah PriteshChief Commercial OfficerFeb 25Sale53.636,377341,98623,710Feb 26 05:56 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerFeb 25Sale53.6318,6471,000,00161,835Feb 26 05:58 PM
Ambrogi Michael J.Chief Operating OfficerFeb 25Sale53.6312,230655,870165,528Feb 26 06:00 PM
Shah PriteshChief Commercial OfficerFeb 22Option Exercise53.3813,000693,94030,087Feb 26 05:56 PM
Kirson Eilon D.Chief Science OfficerFeb 22Option Exercise53.3836,4001,943,032145,463Feb 26 05:57 PM
Longsworth Todd ChristopherGeneral CounselFeb 22Option Exercise53.3821,6671,156,58442,972Feb 26 05:54 PM
Danziger AsafChief Executive OfficerFeb 22Option Exercise53.3853,3332,846,916224,497Feb 26 05:51 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerFeb 22Option Exercise53.3843,3332,313,11680,482Feb 26 05:58 PM
Ambrogi Michael J.Chief Operating OfficerFeb 22Option Exercise53.3831,2001,665,456177,758Feb 26 06:00 PM
LEUNG GABRIELDirectorFeb 11Option Exercise3.445,00017,20065,000Feb 13 04:08 PM
LEUNG GABRIELDirectorFeb 11Sale49.595,000247,95060,000Feb 13 04:08 PM
Ambrogi Michael J.Chief Operating OfficerFeb 04Option Exercise7.1521,000150,150167,558Feb 05 04:16 PM
Ambrogi Michael J.Chief Operating OfficerFeb 04Sale49.5321,0001,040,193146,558Feb 05 04:16 PM
Ambrogi Michael J.Chief Operating OfficerFeb 01Option Exercise7.1537,500268,125184,058Feb 05 04:16 PM
Ambrogi Michael J.Chief Operating OfficerFeb 01Sale49.0337,5001,838,654146,558Feb 05 04:16 PM
Longsworth Todd ChristopherGeneral CounselJan 25Option Exercise7.1511,87484,89933,179Jan 28 04:15 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerJan 25Option Exercise3.4435,000120,40072,149Jan 28 04:12 PM
LEUNG GABRIELDirectorJan 25Option Exercise3.4420,00068,80080,000Jan 28 04:13 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerJan 25Sale49.2035,0001,722,00037,149Jan 28 04:12 PM
LEUNG GABRIELDirectorJan 25Sale50.0020,0001,000,00060,000Jan 28 04:13 PM
Longsworth Todd ChristopherGeneral CounselJan 25Sale50.1511,874595,48121,305Jan 28 04:15 PM
Longsworth Todd ChristopherGeneral CounselJan 24Option Exercise7.1515,000107,25036,305Jan 28 04:15 PM
Longsworth Todd ChristopherGeneral CounselJan 24Sale48.1515,000722,25021,305Jan 28 04:15 PM
Danziger AsafChief Executive OfficerJan 23Option Exercise7.4888,695663,439259,859Jan 25 04:10 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerJan 23Option Exercise3.4435,000120,40072,149Jan 25 04:12 PM
Danziger AsafChief Executive OfficerJan 23Sale47.4888,6954,211,239171,164Jan 25 04:10 PM
open in yahoo | open in reuters | open in google